• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

POVACOAT,一种亲水性共聚物聚(乙烯醇/丙烯酸/甲基丙烯酸甲酯)作为热熔挤出载体的应用和功能特性。

Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.

机构信息

Department of Pharmaceutics, Shenyang Pharmaceutical University , Shenyang , China.

出版信息

Drug Dev Ind Pharm. 2014 Jan;40(1):126-35. doi: 10.3109/03639045.2012.752497. Epub 2013 Jan 22.

DOI:10.3109/03639045.2012.752497
PMID:23336809
Abstract

OBJECTIVE

The aim of this study was to evaluate the applicability of POVACOAT™, a hydrophilic PVA copolymer, as a solid dispersion (SD) carrier for hot-melt extrusion (HME).

METHODS

Bifendate (DDB), a water-insoluble drug, was chosen as the model drug. DDB was hot-melt extruded by a co-rotating twin screw extruder with POVACOAT™. The SD formability of POVACOAT™ was investigated by varying the composition ratios. Solid state characterization was evaluated by differential scanning calorimetry, powder X-ray diffraction, scanning electron microscopy and Fourier transformation infrared spectroscopy. In order to have a better knowledge of the mechanism of dissolution enhancement, dissolution study, phase solubility study and crystallization study of DDB from supersaturated solutions were performed. In addition, the storage stability of the extrudate containing 10% DDB was investigated.

RESULTS

Physical characterizations showed that DDB was amorphous up to 15% drug loading. The phase solubility study revealed an AL-type curve. Moreover, POVACOAT™ was found to have an inhibitory effect on crystallization from supersaturated solutions. Compared with the pure DDB and physical mixture, the dissolution rate and solubility of extrudates were significantly enhanced and the drug loading markedly affected the dissolution of SDs. Furthermore, the stability test indicated that 10% DDB-SD was stable during storage (40 °C/75% RH).

CONCLUSION

The results of this study demonstrate that POVACOAT™ is a valuable excipient for the formulation of solid dispersions prepared by HME to improve dissolution of poorly water-soluble drugs.

摘要

目的

本研究旨在评估亲水性 PVA 共聚物 POVACOAT™作为热熔挤出(HME)用固体分散体(SD)载体的适用性。

方法

选择难溶性药物双飞人(DDB)作为模型药物。通过双螺杆挤出机与 POVACOAT™共挤出熔融挤出 DDB。通过改变组成比来研究 POVACOAT™的 SD 形成能力。通过差示扫描量热法、粉末 X 射线衍射、扫描电子显微镜和傅里叶变换红外光谱对固态特征进行评估。为了更好地了解溶解增强的机制,对 DDB 从过饱和溶液中的溶解、相溶解度和结晶进行了研究。此外,还研究了含有 10%DDB 的挤出物的储存稳定性。

结果

物理特性表明,DDB 在高达 15%的药物载量下呈无定形状态。相溶解度研究显示为 AL 型曲线。此外,发现 POVACOAT™对过饱和溶液中的结晶具有抑制作用。与纯 DDB 和物理混合物相比,挤出物的溶解速率和溶解度显著提高,药物载量明显影响 SD 的溶解。此外,稳定性试验表明,在储存过程中(40°C/75%RH),10%DDB-SD 稳定。

结论

本研究结果表明,POVACOAT™是通过 HME 制备改善难溶性药物溶解的固体分散体的有价值的赋形剂。

相似文献

1
Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.POVACOAT,一种亲水性共聚物聚(乙烯醇/丙烯酸/甲基丙烯酸甲酯)作为热熔挤出载体的应用和功能特性。
Drug Dev Ind Pharm. 2014 Jan;40(1):126-35. doi: 10.3109/03639045.2012.752497. Epub 2013 Jan 22.
2
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.评价聚合物载体对热熔挤出法制备的双芬酸盐固体分散体生物利用度增强的影响。
Drug Dev Ind Pharm. 2012 Jun;38(6):735-43. doi: 10.3109/03639045.2011.623703. Epub 2011 Oct 15.
3
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
4
A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.一种新型可挤出的羟丙甲纤维素:AFFINISOL™ HPMC HME。
AAPS PharmSciTech. 2016 Feb;17(1):106-19. doi: 10.1208/s12249-015-0395-9. Epub 2015 Sep 4.
5
The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.利用药物-聚合物相互作用提高热熔挤出固体分散体的化学稳定性。
J Pharm Pharmacol. 2014 Feb;66(2):285-96. doi: 10.1111/jphp.12145. Epub 2013 Oct 25.
6
Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.应用聚合物载体混合物通过热熔挤出技术提高非诺贝特的溶出度。
Int J Pharm. 2012 Jun 15;429(1-2):58-68. doi: 10.1016/j.ijpharm.2012.03.009. Epub 2012 Mar 13.
7
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.热熔挤出比卡鲁胺-聚乙烯吡咯烷酮固体分散体的理化性质表征。
J Pharm Sci. 2010 Mar;99(3):1322-35. doi: 10.1002/jps.21914.
8
A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.喷雾干燥法和热熔挤出法对含非洛地平无定形固体分散体性质影响的比较研究。
J Pharm Pharmacol. 2014 Feb;66(2):275-84. doi: 10.1111/jphp.12099. Epub 2013 Jul 10.
9
Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.固定剂量形式的热熔共配制抗疟固体分散体系统(ARLUMELT)的研发:评估非晶态及体内性能。
Int J Pharm. 2015 Dec 30;496(1):137-56. doi: 10.1016/j.ijpharm.2015.09.069. Epub 2015 Oct 22.
10
Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.通过热熔挤出和条粒化制备双聚合物无定形固体分散体的配方性能和可加工窗口。
Int J Pharm. 2018 Dec 20;553(1-2):408-421. doi: 10.1016/j.ijpharm.2018.10.035. Epub 2018 Oct 14.

引用本文的文献

1
Polymer Characteristics for Drug Layering on Particles Using a Novel Melt Granulation Technology, MALCORE.使用新型熔融造粒技术 MALCORE 对颗粒进行药物包衣的聚合物特性。
AAPS PharmSciTech. 2024 Apr 10;25(4):81. doi: 10.1208/s12249-024-02798-7.
2
Application of the combination of ball-milling and hot-melt extrusion in the development of an amorphous solid dispersion of a poorly water-soluble drug with high melting point.球磨与热熔挤出联用在开发高熔点难溶性药物无定形固体分散体中的应用
RSC Adv. 2019 Jul 17;9(39):22263-22273. doi: 10.1039/c9ra00810a.
3
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.
重组无序的无定形药物制剂科学的必要性。
Pharm Res. 2017 Sep;34(9):1754-1772. doi: 10.1007/s11095-017-2174-7. Epub 2017 May 18.
4
A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.基于非甾体抗炎药理化性质选择共形成剂以设计稳定共无定形制剂的策略
Pharm Res. 2016 Apr;33(4):1018-29. doi: 10.1007/s11095-015-1848-2. Epub 2015 Dec 24.